EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Socioeconomic dispersion of publicly funded intravenous iron therapies for iron deficiency during pregnancy in Australia: a retrospective population-based cohort study

Hannah Jackson iD, Luke Grzeskowiak iD, Joanne Enticott iD, Sarah Wise iD, Emily Callander iD

Public Health Research & Practice · 10.12.2026 · 36 (4)

DOI: 10.1071/pu25102 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Public Health Research & Practice, online erschienen am 05.11.2026. Verfasst von Hannah Jackson und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Faculty of Health, University of Technology Sydney, NSW, Australia. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Iron. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Technology Sydney, National Health and Medical Research Council (NHMRC) Fellowship, Channel 7 Children's Research Foundation Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Iron deficiency in pregnancy poses significant risks to maternal and fetal health, which are exacerbated by socioeconomic disadvantage. The objective of this study was to assess the socioeconomic distribution of publicly funded intravenous iron therapies for iron deficiency in pregnant women, evaluating the capacity of public policy to promote equal access to medications. Study type Retrospective, population-based cohort study.

Methods

The Maternity1000 dataset was used to analyse access to and public expenditure on intravenous iron therapies dispensed via the Pharmaceutical Benefits Scheme (PBS) during 176,036 pregnancies (July 2015 to June 2018) in Queensland, Australia; stratified by socioeconomic status. Inequalities were assessed through benefit incidence analyses and concentration indices (C).

Results

Diagnosed iron deficiency was more common among women living in less disadvantaged areas (Q5: 7.58% vs Q1: 5.06%). Access to ferric carboxymaltose showed no significant socioeconomic-related inequality overall (Coverall = 0.004; P = 0.594). However, annual concentration indices increased incrementally over the study timeframe, with a small shift in the distribution of access towards women living in less disadvantaged areas in 2017/18 (C2017/18 = 0.038; P < 0.001). In contrast, access to iron polymaltose showed no evidence of socioeconomic inequality (Coverall = −0.024; P = 0.358). Government expenditure on iron polymaltose was consistently concentrated among more disadvantaged areas; reflecting its lower cost and reduced government contribution for less disadvantaged women. Government expenditure on ferric carboxymaltose was evenly distributed overall (Coverall = −0.011; P = 0.130), with annual stratification showing public expenditure became increasingly concentrated among less disadvantaged areas in 2017/18 (C2017/18 = 0.027; P = 0.011).

Conclusions

The PBS plays an important role in supporting intravenous iron access in pregnancy, although minor socioeconomic disparities may be emerging for newer, higher-cost formulations. Ongoing monitoring is needed to ensure rising public expenditure delivers equitable, high-value maternal care without deepening existing inequalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Iron-DeficiencyIronHumansFemalePregnancyRetrospective StudiesAdultSocioeconomic Disparities in HealthQueenslandAustraliaSocioeconomic FactorsFerric CompoundsMaltoseAdministration, IntravenousHealth Services Accessibility

Stichwörter der Autor:innen

anemia, iron deficiencycosts and cost analysisdatasetdrugsequityinequalitymaternal healthmedicationobstetricpharmaceutical preparationssurveillance

Substanzen

IronFerric CompoundsMaltoseferric carboxymaltose

Autor:innen und Institutionen

  • School of Public Health, Faculty of Health, University of Technology Sydney, NSW, Australia.
  • College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
  • SAHMRI Women and Kids, South Australian Health and Medical Research Institute, Adelaide, SA, Australia.
  • Monash Centre for Health Research and Implementation (MCHRI), Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Vic, Australia.

ORCID-Profile: Hannah Jackson, Luke Grzeskowiak, Joanne Enticott, Sarah Wise, Emily Callander

Förderung

  • University of Technology Sydney
  • National Health and Medical Research Council (NHMRC) Fellowship
  • Channel 7 Children's Research Foundation Fellowship

Zitieren

APA

Jackson, H., Grzeskowiak, L., Enticott, J., Wise, S., & Callander, E. (2026). Socioeconomic dispersion of publicly funded intravenous iron therapies for iron deficiency during pregnancy in Australia: a retrospective population-based cohort study. Public Health Research & Practice, 36(4). https://doi.org/10.1071/pu25102

Vancouver

Jackson H, Grzeskowiak L, Enticott J, Wise S, Callander E. Socioeconomic dispersion of publicly funded intravenous iron therapies for iron deficiency during pregnancy in Australia: a retrospective population-based cohort study. Public Health Research & Practice. 2026;36(4). doi:10.1071/pu25102

BibTeX
@article{Jackson2026,
  author = {Jackson, Hannah and Grzeskowiak, Luke and Enticott, Joanne and Wise, Sarah and Callander, Emily},
  title = {Socioeconomic dispersion of publicly funded intravenous iron therapies for iron deficiency during pregnancy in Australia: a retrospective population-based cohort study},
  journal = {Public Health Research & Practice},
  year = {2026},
  volume = {36},
  number = {4},
  doi = {10.1071/pu25102}
}
Kostenlos starten →